Announcements Trials
Browse Landscape

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Neoplasms 12Prostatic Neoplasms 7Lung Neoplasms 6Colorectal Neoplasms 5Breast Neoplasms 5Recurrence 4Multiple Myeloma 4Lymphoma, B-Cell 4Lymphoma 4Urinary Bladder Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Head and Neck Neoplasms 3Carcinoma, Renal Cell 3Cancer Pain 3Urologic Neoplasms 2Triple Negative Breast Neoplasms 2Solid Tumor 2Small Cell Lung Carcinoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Pain 2Ovarian Neoplasms 2Non-Muscle Invasive Bladder Neoplasms 2Neoplasm Metastasis 2Melanoma 2Lymphoma, Follicular 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Acute 2Leukemia 2Kidney Neoplasms 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Spondylarthritis × 90 days × Clear all
NCT02450396 2026-03-27

EGR2

Assistance Publique - Hôpitaux de Paris

Withdrawn
Myeloid

Arthritis, Rheumatoid, Lupus Erythematosus, Systemic, Mastocytosis, Myositis, Sjogren's Syndrome, Vasculitis, Arthritis, Psoriatic, Antiphospholipid Syndrome, Spondylarthritis, Rare Diseases, Scleroderma, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡